The largest safety study performed on both HCQ and HCQ+AZM suggests that the combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality.
Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible.
Central government has approved release of Hydroxychloroquine (HCQ) for 13 countries.
Director of Delhi AIIMS Randeep Guleria said that taking Hydroxychloroquine (HCQ) can be harmful if taken without any prescription by a medical practitioner.
Top News
Latest News
